Animal experiments and analysis of patient records suggest that taking glucosamine is safe for a healthy brain but is associated with further decline in diseased brains.

NutraBio reports that weight loss through GLP-1 medications raises concerns about muscle loss, urging users to prioritize protein and resistance training.

The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.

Aeroflow Breastpumps reports that integrative prenatal care addresses not just clinical safety but also nutrition, stress, and well-being for better outcomes.

Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.